Evidence Receipt. Related Resources.
Evidence Receipt. Related Resources.
Compared to this week’s papers
Verification pending
Use This Via API or MCP
Signal Canvas is the citation-first public layer for turning one paper into a structured commercialization narrative. Use it to hand off into REST, MCP, Build Loop, and launch-pack execution without losing source lineage.
Use This Via API or MCP
Route this paper proof surface into REST, MCP, or developer workflows while preserving the same evidence receipt and related-resource context.
Page Freshness
Canonical route: /signal-canvas/evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation
This page is showing the last landed evidence receipt and score bundle because the latest proof data is outside the freshness window.
Agent Handoff
Canonical ID evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation | Route /signal-canvas/evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation
REST example
curl https://sciencetostartup.com/api/v1/agent-handoff/signal-canvas/evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotationMCP example
{
"tool": "search_signal_canvas",
"arguments": {
"mode": "paper",
"paper_ref": "evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation",
"query_text": "Summarize Evaluating Interactive 2D Visualization as a Sample Selection Strategy for Biomedical Time-Series Data Annotation"
}
}source_context
{
"surface": "signal_canvas",
"mode": "paper",
"query": "Evaluating Interactive 2D Visualization as a Sample Selection Strategy for Biomedical Time-Series Data Annotation",
"normalized_query": "2603.26592",
"route": "/signal-canvas/evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation",
"paper_ref": "evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation",
"topic_slug": null,
"benchmark_ref": null,
"dataset_ref": null
}Claims: 8
References: 80
Proof: Verification pending
Freshness state: computing
Source paper: Evaluating Interactive 2D Visualization as a Sample Selection Strategy for Biomedical Time-Series Data Annotation
PDF: https://arxiv.org/pdf/2603.26592v1
Source count: 3
Coverage: 50%
Last proof check: 2026-03-30T21:58:10.273Z
Signal Canvas receipt window
/buildability/evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation
Subject: Evaluating Interactive 2D Visualization as a Sample Selection Strategy for Biomedical Time-Series Data Annotation
Verdict
Ignore
Verdict is Ignore because current viability and proof state do not clear the buildability gate.
Preparing verified analysis
Dimensions overall score 4.0
No public code linked for this paper yet.
Across all classification tasks, 2DV performed best when aggregating labels across annotators.
This is a primary finding explicitly stated in the abstract and supported by the overall results.
partial
In IMA, 2DV most effectively captured rare classes
This is a specific result mentioned in the abstract regarding the performance of 2DV in a particular domain.
partial
but also exhibited greater annotator-to-annotator label distribution variability resulting from the limited annotation budget, decreasing classification performance when models were trained on individual annotators' labels
This is a specific limitation and its consequence for the 2DV method in IMA, clearly stated in the abstract.
partial
in these cases, FAFT excelled.
This is a comparative result highlighting the strength of FAFT in a specific scenario where 2DV struggled.
partial
For SER, 2DV outperformed the other methods among expert annotators and matched their performance for non-experts in the individual-annotator setting.
This is a specific result detailing the performance of 2DV across different annotator expertise levels in SER.
partial
A failure risk analysis revealed that RND was the safest choice when annotator count or annotator expertise was uncertain, whereas 2DV had the highest risk due to its greater label distribution variability.
This is a direct conclusion from the failure risk analysis, clearly stated in the abstract.
partial
Furthermore, post-experiment interviews indicated that 2DV made the annotation task more interesting and enjoyable.
This is a qualitative finding from post-experiment interviews, indicating a benefit of the 2DV method.
partial
Overall, 2DV-based sampling appears promising for biomedical time-series data annotation, particularly when the annotation budget is not highly constrained.
This is the overarching conclusion of the study, summarizing the potential of the 2DV method.
partial
Related resources will appear here when this paper maps cleanly to topic, benchmark, or dataset surfaces.
Use an AI coding agent to implement this research.
Lightweight coding agent in your terminal.
Agentic coding tool for terminal workflows.
AI agent mindset installer and workflow scaffolder.
AI-first code editor built on VS Code.
Free, open-source editor by Microsoft.
Estimated $9K - $13K over 6-10 weeks.
See exactly what it costs to build this -- with 3 comparable funded startups.
7-day free trial. Cancel anytime.
Discover the researchers behind this paper and find similar experts.
7-day free trial. Cancel anytime.
Time to first demo
Insufficient data
No first-demo timestamp, owner estimate, or elapsed demo receipt is attached to this surface.
Structured compute envelope
Insufficient data
No data, compute, hardware, memory, latency, dependency, or serving requirement receipt is attached.
Receipt path
/buildability/evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation
Paper ref
evaluating-interactive-2d-visualization-as-a-sample-selection-strategy-for-biomedical-time-series-data-annotation
arXiv id
2603.26592
Generated at
2026-03-30T21:58:10.273Z
Evidence freshness
stale
Last verification
2026-03-30T21:58:10.273Z
Sources
3
References
80
Coverage
50%
Lineage hash
0ee2f6573e81ed63a397ab5e950aeb924452d3acc52af590b11806d03a3a57a8
Canonical opportunity-kernel lineage hash.
External signature
unsigned_external
No founder, registry, pilot, or production-adoption signature is attached to this receipt.
Verification
not_verified
Verification is blocked until an external signature is provided.
80 refs / 3 sources / Verification pending
repo_url
proof_status